Page last updated: 2024-08-22

angiotensin ii and End Stage Liver Disease

angiotensin ii has been researched along with End Stage Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adelmann, D; Bokoch, MP; Brinson, EL; Fields, S; Kothari, RP; Legrand, M; Marcus, SG; Pardo, M; Reddy, M; Roll, GR; Sun, E; Tran, AT	1

Trials

1 trial(s) available for angiotensin ii and End Stage Liver Disease

Article	Year
Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial. BMJ open, 2023, 11-19, Volume: 13, Issue:11 Topics: Adult; Angiotensin II; Catecholamines; Double-Blind Method; End Stage Liver Disease; Humans; Hypotension; Liver Transplantation; Living Donors; Multicenter Studies as Topic; Norepinephrine; Randomized Controlled Trials as Topic; Severity of Illness Index; Vasoconstrictor Agents	2023

Article

Year

Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.

BMJ open, 2023, 11-19, Volume: 13, Issue:11

Topics: Adult; Angiotensin II; Catecholamines; Double-Blind Method; End Stage Liver Disease; Humans; Hypotension; Liver Transplantation; Living Donors; Multicenter Studies as Topic; Norepinephrine; Randomized Controlled Trials as Topic; Severity of Illness Index; Vasoconstrictor Agents

2023